RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Lake Charles, LA · +46 more sites
Clinical trials in Lake Charles, LA
19 recruiting studies have a site in or near Lake Charles, LA, Louisiana.
Top conditions here
- Rheumatoid Arthritis (6)
- Lupus (6)
- Type 2 Diabetes (2)
- COPD (2)
- Psoriasis (2)
- Obesity (1)
- Alzheimer's Disease (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 19 of 19 studies
RecruitingPhase 2NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Sponsor: Hoffmann-La Roche
Lake Charles, LA · +17 more sites
RecruitingPhase 2NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Lake Charles, LA · +4 more sites
RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Baton Rouge, LA · Lake Charles, LA · New Orleans, LA · +60 more sites
RecruitingPhase 3NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Sponsor: Takeda
Lake Charles, LA · +52 more sites
RecruitingNot applicableNCT04101669
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Sponsor: Morphic Medical Inc.
Lake Charles, LA · +26 more sites
RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Lake Charles, LA · New Orleans, LA · +23 more sites
RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Covington, LA · Lake Charles, LA · Metairie, LA · +119 more sites
RecruitingPhase 2NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Sponsor: AstraZeneca
Lake Charles, LA · +28 more sites
RecruitingPhase 2NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Sponsor: AbbVie
Lake Charles, LA · +48 more sites
RecruitingPhase 3NCT07355218
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Sponsor: EMD Serono Research & Development Institute, Inc.
Lake Charles, LA · +13 more sites
RecruitingPhase 3NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Lake Charles, LA · +30 more sites
RecruitingPhase 3NCT07438496
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Sponsor: Janssen Research & Development, LLC
Lake Charles, LA · +37 more sites
RecruitingPhase 3NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Lake Charles, LA · +40 more sites
RecruitingPhase 3NCT07780669
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Sponsor: GlaxoSmithKline
Lake Charles, LA · +1 more sites
RecruitingPhase 4NCT07611214
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Sponsor: Aurinia Pharmaceuticals Inc.
Lake Charles, LA · +26 more sites
RecruitingPhase 3NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sponsor: GlaxoSmithKline
Lake Charles, LA · Shreveport, LA · +40 more sites
RecruitingPhase 2NCT07409103
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Sponsor: Elevara Medicines Limited
Lake Charles, LA · +21 more sites
RecruitingPhase 3NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Sponsor: Eli Lilly and Company
Lake Charles, LA · +51 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.